Clinical Trial Update: DermaSensor Study of Primary Care Physician Use of Elastic-Scattering Spectroscopy (ESS) on Skin Lesions Suggestive of Skin Cancer

View source ↗

Summary

A completed clinical trial evaluating how primary care physicians use elastic-scattering spectroscopy to assess skin lesions suspected of skin cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer

Drugs mentioned

• Elastic-Scattering Spectroscopy (ESS) device (elastic-scattering spectroscopy device)

Snippet

Sponsor: DermaSensor, Inc. | Conditions: Skin Cancer | Status: COMPLETED